Tag: Uti vaccine

According to the European Association of Urology, a long-term follow-up study showed that 54% of participants with recurrent UTIs remained infection-free for up to nine years after vaccination with Uromune. For those wondering where can I get Uromune, the answer depends heavily on geographical location, as this promising treatment is not universally approved or available.

Recurrent urinary tract infections (rUTIs) are common, with an estimated 30% to 44% of women experiencing a second UTI within six months of the first [1.8.1]. This article explores a key question for many sufferers: Why is Uromune not available in the US as a treatment option?

Recurrent urinary tract infections (rUTIs) are a significant burden, affecting millions globally. This has driven demand for non-antibiotic solutions like the sublingual vaccine MV140 (Uromune), leading many to ask: is the MV140 available in the US? Currently, the answer is no, as it has not yet received approval from the U.S. Food and Drug Administration (FDA).